The contribution of hormonal profile changes to determining cardiac prognosis in patients with stable coronary artery disease undergoing coronary revascularization

One of the factors influencing cardiac prognosis is changes in the balance of hormonal and metabolic parameters in the blood, particularly leptin, resistin, and testosterone, which are involved in chronic subclinical inflammation. The potential for using these markers in clinical practice formed the basis for the development of a prognostic model for determining cardiac prognosis after percutaneous coronary interventions with coronary artery stenting in patients with stable coronary artery disease, which was the aim of this study. It was shown that increased leptin and resistin levels, as well as decreased serum testosterone levels in patients with stable coronary artery disease, are associated with an increased risk of adverse cardiovascular outcomes within a year of coronary revascularization. In addition, an assessment was made of the influence of leptin, resistin, and testosterone levels on the outcome within 12 months after myocardial revascularization by constructing a prognostic model that allows assessing the likelihood of developing adverse cardiac events.

1. Khudiakova A.D., Polonskaya Y.V., Shcherbakova L.V., Shramko V.S., Kuzminykh N.A., Kashtanova E.V., Ragino Yu.I. Associations of circulating adipokines and coronary artery disease in young adults. Cardiovascular Therapy and Prevention. 2024;23(5):3965. (In Russ.) DOI: 10.15829/1728-8800-2024-3965

2. Raman P, Khanal S. Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells. Int J Mol Sci. 2021;22(11):5446. DOI: 10.3390/ijms22115446

3. Koshelskaya O.A., Kharitonova O.A., Kologrivova I.V., Suslova T.E., Margolis N.Y., Tereshenkova E.K.,et al. Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2. Terapevticheskii arkhiv. 2021;93(9):1030-1036. DOI: 10.26442/00403660.2021.09.201032

4. Cai M, Zhao D, Han X, Han S, Zhang W, Zang Z, et al. The role of perivascular adipose tissue-secreted adipocytokines in cardiovascular disease. Front Immunol. 2023;14:1271051. DOI: 10.3389/fimmu.2023.1271051

5. Djuraeva N.M., Ikramov A.I., Khaibullina Z.R., Abdukhalimova K.V., Tursunova L.N. Relationship between proinflammatory adipocytokine levels and volumetric-linear parameters of ectopic fat depots in patients with coronary heart disease. The Bulletin of Contemporary Clinical Medicine. 2023;16(Suppl. 2):13-18. (In Russ.) DOI:10.20969/VSKM.2023.16(suppl.2).13-18.

6. Rahmani A, Toloueitabar Y, Mohsenzadeh Y, Hemmati R, Sayehmiri K, Asadollahi K. Association between plasma leptin/adiponectin ratios with the extent and severity of coronary artery disease. BMC Cardiovasc Disord. 2020;20(1):474. DOI: 10.1186/s12872-020-01723-7

7. Rachwalik M, Hurkacz M, Sienkiewicz-Oleszkiewicz B, Jasiński M. Role of resistin in cardiovascular diseases: Implications for prevention and treatment. Adv Clin Exp Med. 2021;30(8):865-874. DOI: 10.17219/acem/135978

8. Pastusiak K, Kregielska-Narozna M, Bogdanski P. Resistin is not a useful insulin resistance marker for non-obese patients. J Physiol Pharmacol. 2020;71(3). DOI: 10.26402/jpp.2020.3.06

9. Alieva A.M., Baykova I.V., Khadzhieva N.Kh., Ettinger O.A., Arakelyan R.A., Valiev R.K., et al. Resistin and cardiovascular pathology. Therapy. 2021;7.(9):137-147. (in Russ.) DOI: 10.18565/therapy.2021.9.137-147

10. Kisilenko E.V., Sobole A.D., Cherkashin D.V. Patients with "Special" Cardiovascular Risk. Modern Aspects of the Need for Preventive Monitoring of Young People with Low Severity of Predictors of Cardiovascular Diseases. Doctor.ru. 2023;22(8):33-39. (In Russ.) DOI: 10.31550/1727-2378-2023-22-8-33-39

11. Polonskaya Ya.V., Kashtanova E.V., Stakhneva E.M., Ledovskikh S.R., Garbuzova E.V., Shramko V.S., et al. Levels of metalloproteinases and adipose tissue hormones in men with coronary atherosclerosis. Bulletin of Siberian Medicine. 2023;22(4):73-78. DOI: 10.20538/1682-0363-2023-4-73-78

12. Grekov E.A., Dzidzaria A.G., Tyuzikov I.A. Sex steroids binding globulin: the evolution of views about biological functions and diagnostic significans and pathological conditions. Andrology and genital surgery. 2024;25(1):49-62. (in Russ.) eLIBRARY ID: 67266986 EDN: GAFDTA

13. Enina T.N., Kuznetsov V.A., Soldatova A.M. Testosterone and congestive heart failure. Kardiologiia. 2022;62(7):61-67. (In Russ.) https://doi.org/10.18087/cardio.2022.7.n1242

14. Kaur H, Werstuck GH. The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data. CJC Open. 2021;3(10):1238-1248. DOI: 10.1016/j.cjco.2021.05.007

15. Barbarash O.L., Karpov Yu.A., Panov A.V., Akchurin R.S., Alekyan B.G., Alekhin M.N., et al. 2024 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2024;29(9):6110. (In Russ.) DOI: 10.15829/1560-4071-2024-6110

16. Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537. Erratum in: Eur Heart J. 2025;46(16):1565. DOI: 10.1093/eurheartj/ehae177.

17. Khafaji HA, Bener AB, Rizk NM, Al Suwaidi J. Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findings. BMC Res Notes. 2012;5:262. DOI: 10.1186/1756-0500-5-262

18. Gorbatovskaya E.E., Dyleva Ya.A., Belik E.V., Uchasova E.G., Tarasov R.S., Kashtalap V.V., Gruzdeva O.V. Clinical and prognostic value of leptin resistance in the hospital period of myocardial infarction. Bulletin of Siberian Medicine. 2023;22(3):14-24. (In Russ.) DOI: 10.20538/1682-0363-2023-3-14-24

19. Avsaragova AZ, Astakhova ZT, Remizov OV, Toguzova ZA, Gazzaeva SA, Bestaev EV. Interfering effect of serum resistin and C-reactive protein in patients with acute coronary syndrome on risk factors of subsequent syndromes. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;17(2):133‑138. (In Russ.) DOI: 10.17116/kardio202417021133

20. Draganova A.S., Polyakova E.A., Belyaeva O.D., Bazhenova E.A., Kulikova E.V., Karonova T.L. et al. Predictors of unfavorable prognosis in patients with acute coronary syndrome without ST-segment elevation who underwent percutaneous coronary intervention // Atherosclerosis and dyslipidemia. 2020;(3):30-41. (in Russ.). DOI: 10.34687/2219-8202.JAD.2020.03.0003

21. Akhmatokhunova M.K. Androgen deficiency and cardiovascular diseases. Re-health journal. 2023;(1):67-70. (In Russ.).